Selvita Team Grows to Over 250 People
News Aug 11, 2015
Selvita has been intensively expanding its operations. The total employment at Selvita increased to 261 people, including 86 PhDs in August.
The period of 2014-2015 marks a significant increase for Selvita in terms of revenue and operations, both in its drug discovery outsourcing segment as well in the internal pipeline.
The company has recently signed several large and long-term services contracts in the area of medicinal and analytical chemistry with some of the most renowned pharma companies.
Selvita has also been successively expanding its capabilities in terms of proteomics, which has effected in establishing new collaborations also in this area.
The employment has been increasing accordingly, from 173 people in 2013, to 230 at the end of 2014.
Selvita is continuously investing in new laboratory infrastructure and highly qualified scientific staff, aiming to provide best quality integrated drug discovery services to pharmaceutical and biotechnology companies.
Researchers Fine-Tune Computer-Assisted Drug Repositioning Process to Treat Rare DiseasesNews
Researchers at the LSU Computational Systems Biology group have developed a sophisticated and systematic way to identify existing drugs that can be repositioned to treat a rare disease or condition.READ MORE
So Hot it Hurts: Ion channel trio underlying painful heat sensation foundNews
Researchers show that acute noxious heat sensing in mice depends on a triad of transient receptor potential (TRP) ion channels: TRPM3, TRPV1, and TRPA1.READ MORE
'Body-on-a-Chip' Could Advance Drug EvaluationNews
MIT engineers have developed new technology that could be used to evaluate new drugs and detect possible side effects before the drugs are tested in humans. Using a microfluidic platform that connects engineered tissues from up to 10 organs, the researchers can accurately replicate human organ interactions for weeks at a time.READ MORE